General
Preferred name
SULFAMETHOXYPYRIDAZINE
Synonyms
CL 13494 ()
Retasulphine ()
CL-13494 ()
Sulfametoxipiridazina ()
NSC-757875 ()
Sulfamethoxypyridazinum ()
Lederkyn ()
Sulfasuxidine ()
Depovernil ()
Succinylsulfathi ()
P&D ID
PD001487
CAS
80-35-3
Tags
available
drug
First approval
1960
Drug Status
approved
withdrawn
experimental
Max Phase
4.0
Drug indication
bacterial disease
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Sulfamethoxypyridazine is a sulfonamide antibacterial compound .
(GtoPdb)
DESCRIPTION
Sulfamethoxypyridazine is a long-acting sulfonamide antibiotic, for treatment of Dermatitis herpetiformis.
PRICE
29
DESCRIPTION
Sulfamethoxypyridazine is a long-acting sulfonamide antibiotic. It is used for treatment of Dermatitis herpetiformis
(BOC Sciences Bioactive Compounds)
DESCRIPTION
Sulfamethoxypyridazine (CL 13494) is a sulfanilamide antibacterial agent.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
17
BOC Sciences Bioactive Compounds
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugCentral
DrugCentral Approved Drugs
DrugMatrix
Guide to Pharmacology
MedChem Express Bioactive Compound Library
NPC Screening Collection
Prestwick Chemical Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
Withdrawn 2.0
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
28
Molecular Weight
280.06
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
2
Rotatable Bonds
4
Ring Count
2
Aromatic Ring Count
2
cLogP
0.87
TPSA
107.2
Fraction CSP3
0.09
Chiral centers
0.0
Largest ring
6.0
QED
0.8
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
antibiotic
Bacterial
PD-1/PD-L1
MOA
bacterial antifolate
ATC
J01ED05
Toxicity type
dermatological
Pathway
Apoptosis
Cell Cycle/Checkpoint
Immunology/Inflammation
Microbiology/virology
Anti-infection
Solubility
DMSO:42mg/mL
Source data
